Coverage
-
October 05, 2020
A Federal Circuit judge peppered Vectura Limited's counsel with tough questioning Monday, suggesting that attorneys for the U.K.-based pharmaceutical company defied a Delaware federal court's instructions during jury trial last year, which may warrant a retrial of the nearly $107 million verdict in an inhaler patent dispute.
4 other articles on this case.
View all »